Two boys with high grade fever (Page 1/2)
Prepared by...
Alanh Khounnasene, MD*
Thanyawee Puthanakit, MD**
*Division of Postgrad Studies and Research,
Faculty of Medical Sciences, National University of Laos
**Department of Pediatrics, Chiang Mai University
 
Case 1: A 13-year-old boy with high grade fever
 

Patient: A 13-year-old boy

Address: Chiang Mai
CC: Fever for 4 days
PI:
4 days PTA: he started to have high grade fever with chills, and headache
2 days PTA: while his high grade fever persisted he developed right upper quadrant
pain, vomiting (2 times), no hematemesis anorexia.
1 day PTA: because of his persistent high grade fever he was taken to the community hospital.
Vital sign: BT 38.5 C, BP 100/65 mmHg, PR 90/min PE: tenderness at right upper quadrant, liver just palpable, tourniquet test positive,
CBC: Hb 14.9g/dl, Hct 48%, WBC 5,800/mm3 (Neu 49%, Lymp 39%),
Platelet 82,000/ mm3. He was diagnosed as "dengue hemorrhagic fever".
PH:
  Underlying disease: asthma, normal development, complete immunization
He lives in Vieng Hang district, Chiang Mai, no history of traveling in the past month
PE:
  GA : normal consciousness, well nourished, BW 42 kg (percentile 50th)
  V/S : BT 39 C, BP 118/68 mmHg, PR 102/min, RR 24/min
  HEENT: no pale conjunctiva, no icteric sclera , pharynx not injected, no tonsil
enlargement, cervical lymph nodes not palpable
  Heart: normal S1 S2, no murmur
  Lung: clear, no adventitious sound
  Abdomen: liver just palpable, spleen not palpable, mild tenderness at right upper quadrant.
  Extremities: no edema, no petechia except at the left ante cubital area (TT+), capillary refill
< 2 sec.
  Skin: no eschar, no rash, normal skin turgor
Initial Laboratory investigations:
  CBC: Hb 13.4g/dl, Hct 38%, WBC 3,900/mm3 (Neu 56%, Lymp 32%, Mono 10%, Eo 2%), Platelet 53,000/ mm3
  UA: RBC: 0-1, WBC: 1-2, PH: 6.5, Sp.gr: 1.015, Alb: +1, Sugar: +1, Epi:2-5cells/HPF
 
What is your provisional diagnosis?
Dengue hemorrhagic fever grade I
 
Treatment: Supportive treatment; hydration and monitoring on dengue chart
 
Progression on day 2 of admission:
Patient still had high grade fever
  VS: BT 39.5 C , BP 100/60 mmHg, PR 120/min, RR 24/min
  CBC: Hb 12.5g/dl, Hct 38%, WBC 4900/mm3 (Neu 59%, Lymp 27%, Mono 11%, Eo 3%), Platelet 67,000/ mm3
Rapid test for Dengue IgG, IgM negative
Peripheral blood smear showed as figure 1.
 
Figure 1: Amoeboid form of Plasmodium vivax in enlarged red blood cell.

 

Definite Diagnosis:
Malaria infection; Plasmodium vivax
 
Treatments:
1. Chloroquine 25 mg base/kg
[Day1: 10 mg/kg/dose then 5 mg/kg/dose 6 hour later, Day 2 and 3: 5 mg/kg/dose]
2. Primaquine 0.3 mg base/kg x 14 days
 
Discussion 1: Diagnosis of P.vivax
> Malaria may be misdiagnosed as a number of other conditions, most importantly meningitis, typhoid fever and septicemia. Other differential diagnoses include haemorrhagic fevers, influenza, hepatitis, scrub typhus, or viral encephalitis.
> Usually the manifestation of P. vivax infection is not typical signs; this case presented with high grade fever for 4 days, tourniquet test positive, hemoconcentration and thrombocytopenia. The clinical symptoms that against DHF are hematocrit decreased while the patient still had high grade fever and other abnormal clinical signs, and predominate polymorphonuclear cell. The blood smear for plasmodium species is necessary for the patient who has fever, especially in endemic areas.
> The characteristics of 4 plasmodium species responsible for human malaria are shown in
table 1
 
Table 1 The characteristics of 4 plasmodium species responsible for human malaria
Copy from: Barnett Ed. Malaria. In: Feigin RD, Cherry JD, Demmler GJ, Kaplan SL. Textbook of Pediatric Infectious Disease. 5th ed. Philadelphia: Suanders; 2004. p. 2717.
 
Discussion 2: Treatment of P.vivax
> Chloroquine is the drug of choice for P.vivax infection in Thailand.
> Primaquine is highly effective against the gametocytes of all plasmodia and thereby prevents spread of the disease to the mosquito from the patient. It is also effective against the dormant tissue forms (hypnozoite) of P. vivax and thereby offers radical cure and prevents relapses. Patients with deficiency of G6 PD may develop hemolytic anemia on taking usual doses of primaquine, therefore patients should be tested for G6 PD deficiency before administering primaquine. If patient has G6PD deficiency, the primaquine should be given 0.9 mg base/kg once a week for 8 weeks.